1. Home
  2. RGNX vs PGC Comparison

RGNX vs PGC Comparison

Compare RGNX & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$7.45

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

HOLD

Current Price

$46.06

Market Cap

769.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNX
PGC
Founded
2008
1921
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
793.5M
769.6M
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
RGNX
PGC
Price
$7.45
$46.06
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$23.58
★ $56.00
AVG Volume (30 Days)
★ 1.3M
92.3K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
★ 0.43%
EPS Growth
★ 18.08
13.51
EPS
N/A
★ 1.65
Revenue
$10,393,000.00
★ $282,995,000.00
Revenue This Year
N/A
$24.36
Revenue Next Year
$23.50
$12.76
P/E Ratio
★ N/A
$27.93
Revenue Growth
★ 126.48
24.05
52 Week Low
$5.46
$24.71
52 Week High
$16.19
$49.14

Technical Indicators

Market Signals
Indicator
RGNX
PGC
Relative Strength Index (RSI) 50.22 60.63
Support Level $6.96 $44.32
Resistance Level $8.31 $47.32
Average True Range (ATR) 0.43 0.96
MACD 0.06 0.34
Stochastic Oscillator 55.77 77.69

Price Performance

Historical Comparison
RGNX
PGC

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.

Share on Social Networks: